A single dose of either TV003 or TV005 induced seroconversion to four DENV serotypes in 74-92% (TV003) and 90% (TV005) of flavivirus seronegative adults and ...
People also ask
Does TV005 dengue vaccine protect against dengue serotype 2 and 3 controlled human infection?
When is dengue season in Brazil?
Is there a vaccine for dengue fever?
What is the live attenuated dengue vaccine?
Safety and durable immunogenicity of the TV005 tetravalent ... - PubMed
pubmed.ncbi.nlm.nih.gov › ...
Interpretation: With 3 years of follow-up, the single-dose tetravalent dengue vaccine, TV005, was well tolerated and immunogenic for all four serotypes in young ...
Sep 27, 2023 · A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults. ... Use in several ...
Feb 1, 2024 · TV005 dengue vaccine protects against dengue serotypes 2 and 3 in two controlled human infection studies.
It shows that TV005 is safe and prompts neutralising antibody responses to all serotypes, which persist for at least 3 years, in adults and adolescents. Waning ...
Feb 1, 2024 · RESULTS. TV005 was well tolerated and protected all vaccinated volunteers from viremia with DENV2 or DENV3 (none infected in either group).
Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh ; Experimental: ...
Follow-up Study of the Immunogeneity and Safety of a Live Attenuated Tetravalent Dengue Vaccine TV005 among Taiwanese Adults 50 to 70 Years of Age: a Phase ...
May 24, 2022 · The development of the live attenuated DENV vaccines called TV003/TV005 began in 1996 at the Laboratory of Infectious Diseases (LID) of the ...
The TV005 vaccine was well tolerated and effectively protected all vaccinated individuals from viremia and rash during challenges with DENV2 or DENV3. Notably, ...